Johnson and Johnson’s pharmaceuticals brand Janssen wants to improve heart health, and for its latest study it’s turning to the iPhone and the Apple Watch to help gain a better understanding of the vital organ. In an announcement Tuesday, the health care giant announced a partnership with Apple on a new Heartline study designed to get more information on heart health among people age 65 and older.
The study’s goal, according to the announcement’s press release, is to “explore if the Heartline Study app on iPhone and heart health features on Apple Watch can improve health outcomes, including reducing the risk of stroke, with earlier detection of atrial fibrillation (AFib).”
The company cites a stat from the US Centers for Disease Control and Prevention that says that AFib, “the most common sustained cardiac arrhythmia, results in 158,000 deaths and 454,000 hospitalizations each year.” It’s hoping that by using the iPhone app and Apple Watch the study will allow for insights from people nationwide as opposed to having to set up individual clinical trial sites.
Read CNET
https://youtu.be/36Hq-ObmSSw
Leave a Reply